TB-500, AOD-9604, and how repair peptides synergize.
TB-500 is a synthetic peptide fragment derived from the active region of Thymosin Beta-4 (Tβ4), a 43-amino-acid protein found naturally in virtually all human and animal cells. TB-500 is not identical to Thymosin Beta-4 — it is a synthesized fragment that contains the key actin-binding domain responsible for the protein's tissue repair properties. TB-500 promotes cell migration — literally helping repair cells travel to the site of injury. It upregulates actin, a protein essential for cell structure and movement. This is why TB-500 excels at healing deep tissue injuries: it recruits your body's repair machinery and helps it reach the damage faster. **Research Status**: Moderate preclinical evidence. Substantial animal studies in wound healing and cardiac repair, plus limited clinical data (corneal formulation RGN-259 in Phase II trials). No FDA approval for systemic use.
TB-500 is a synthetic fragment of Thymosin Beta-4 that promotes cell migration to injury sites — it's the peptide that helps your repair cells find and reach damaged tissue.
BPC-157 and TB-500 are frequently stacked because they work through complementary mechanisms. BPC-157 creates the environment for healing (new blood vessels, reduced inflammation) while TB-500 mobilizes repair cells to the site. Together, they address both the infrastructure and the workforce needed for tissue regeneration. This is why the combination is considered the gold standard in peptide-based repair protocols.
BPC-157 builds the repair infrastructure while TB-500 mobilizes repair cells — together, they create the gold standard repair stack.